vs

Side-by-side financial comparison of Dexcom (DXCM) and Snap-on (SNA). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.0× Snap-on). Snap-on runs the higher net margin — 21.3% vs 21.2%, a 0.1% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 2.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Snap-on Incorporated is an American designer, manufacturer, and marketer of high-end tools and equipment for professional use in the transportation industry, including the automotive, heavy duty, equipment, marine, aviation, and railroad industries. Headquartered in Kenosha, Wisconsin, since 1930, Snap-on also distributes lower-end tools under the brand name Blue-Point. Their primary competitors include Matco, Mac Tools, and Cornwell Tools.

DXCM vs SNA — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.0× larger
DXCM
$1.3B
$1.2B
SNA
Growing faster (revenue YoY)
DXCM
DXCM
+18.9% gap
DXCM
21.6%
2.7%
SNA
Higher net margin
SNA
SNA
0.1% more per $
SNA
21.3%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
2.0%
SNA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
SNA
SNA
Revenue
$1.3B
$1.2B
Net Profit
$267.3M
$260.7M
Gross Margin
62.9%
Operating Margin
25.6%
27.8%
Net Margin
21.2%
21.3%
Revenue YoY
21.6%
2.7%
Net Profit YoY
153.6%
1.0%
EPS (diluted)
$0.67
$4.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
SNA
SNA
Q1 26
$1.3B
Q4 25
$1.3B
$1.2B
Q3 25
$1.2B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.0B
$1.1B
Q4 24
$1.1B
$1.2B
Q3 24
$994.2M
$1.1B
Q2 24
$1.0B
$1.2B
Net Profit
DXCM
DXCM
SNA
SNA
Q1 26
$267.3M
Q4 25
$267.3M
$260.7M
Q3 25
$283.8M
$265.4M
Q2 25
$179.8M
$250.3M
Q1 25
$105.4M
$240.5M
Q4 24
$151.7M
$258.1M
Q3 24
$134.6M
$251.1M
Q2 24
$143.5M
$271.2M
Gross Margin
DXCM
DXCM
SNA
SNA
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
SNA
SNA
Q1 26
25.6%
Q4 25
25.6%
27.8%
Q3 25
20.1%
29.4%
Q2 25
18.4%
28.0%
Q1 25
12.9%
27.7%
Q4 24
17.0%
27.9%
Q3 24
15.3%
28.4%
Q2 24
15.7%
29.9%
Net Margin
DXCM
DXCM
SNA
SNA
Q1 26
21.2%
Q4 25
21.2%
21.3%
Q3 25
23.5%
22.5%
Q2 25
15.5%
21.4%
Q1 25
10.2%
21.2%
Q4 24
13.6%
21.7%
Q3 24
13.5%
22.0%
Q2 24
14.3%
23.1%
EPS (diluted)
DXCM
DXCM
SNA
SNA
Q1 26
$0.67
Q4 25
$0.67
$4.94
Q3 25
$0.70
$5.02
Q2 25
$0.45
$4.72
Q1 25
$0.27
$4.51
Q4 24
$0.37
$4.83
Q3 24
$0.34
$4.70
Q2 24
$0.35
$5.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
SNA
SNA
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
Total Assets
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
SNA
SNA
Q1 26
$917.7M
Q4 25
$917.7M
Q3 25
$1.8B
$1.5B
Q2 25
$1.2B
$1.5B
Q1 25
$904.9M
$1.4B
Q4 24
$606.1M
$1.4B
Q3 24
$621.2M
$1.3B
Q2 24
$939.2M
$1.2B
Total Debt
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
SNA
SNA
Q1 26
$2.7B
Q4 25
$2.7B
Q3 25
$2.7B
$5.8B
Q2 25
$2.6B
$5.7B
Q1 25
$2.3B
$5.5B
Q4 24
$2.1B
$5.4B
Q3 24
$2.0B
$5.5B
Q2 24
$2.4B
$5.3B
Total Assets
DXCM
DXCM
SNA
SNA
Q1 26
$6.3B
Q4 25
$6.3B
Q3 25
$7.5B
$8.4B
Q2 25
$7.3B
$8.2B
Q1 25
$6.8B
$8.1B
Q4 24
$6.5B
$7.9B
Q3 24
$6.4B
$8.0B
Q2 24
$6.8B
$7.8B
Debt / Equity
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
Q3 25
0.21×
Q2 25
0.21×
Q1 25
Q4 24
0.22×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
SNA
SNA
Operating Cash FlowLast quarter
$268.1M
Free Cash FlowOCF − Capex
$254.6M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
$294.0M
$268.1M
Q3 25
$659.9M
$277.9M
Q2 25
$303.0M
$237.2M
Q1 25
$183.8M
$298.5M
Q4 24
$301.4M
$293.5M
Q3 24
$199.5M
$274.2M
Q2 24
$279.4M
$301.1M
Free Cash Flow
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
$192.1M
$254.6M
Q3 25
$579.4M
$258.0M
Q2 25
$208.9M
$217.5M
Q1 25
$96.8M
$275.6M
Q4 24
$176.8M
$275.4M
Q3 24
$88.3M
$253.8M
Q2 24
$213.3M
$277.9M
FCF Margin
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
15.3%
20.8%
Q3 25
47.9%
21.8%
Q2 25
18.1%
18.6%
Q1 25
9.3%
24.3%
Q4 24
15.9%
23.1%
Q3 24
8.9%
22.3%
Q2 24
21.2%
23.7%
Capex Intensity
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
8.1%
1.1%
Q3 25
6.7%
1.7%
Q2 25
8.1%
1.7%
Q1 25
8.4%
2.0%
Q4 24
11.2%
1.5%
Q3 24
11.2%
1.8%
Q2 24
6.6%
2.0%
Cash Conversion
DXCM
DXCM
SNA
SNA
Q1 26
Q4 25
1.10×
1.03×
Q3 25
2.33×
1.05×
Q2 25
1.69×
0.95×
Q1 25
1.74×
1.24×
Q4 24
1.99×
1.14×
Q3 24
1.48×
1.09×
Q2 24
1.95×
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons